<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00951093</url>
  </required_header>
  <id_info>
    <org_study_id>GASTROBESE-004</org_study_id>
    <nct_id>NCT00951093</nct_id>
  </id_info>
  <brief_title>Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass</brief_title>
  <official_title>The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Patients With Morbid Obesity: a Prospective Study Based on Montreal Consensus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Gastrobese</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinica Gastrobese</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal
      reflux disease (GERD) in morbidly obese patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators studied the impact of this surgical procedure on GERD in patients with
      morbid obesity.

      Esophageal syndromes were evaluated according to the Montreal Consensus, where troublesome
      symptoms were defined as score ≥ 2 on a validated questionnaire of symptoms for Portuguese
      language along with esophageal syndromes with injury assessed through upper endoscopy.

      Esophageal acid exposure was determined through 24h pH monitoring. Increased acid exposure
      was characterized when total esophageal pH &lt; 4 for at least 4% of the total monitoring time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Presenting Reflux Symptoms</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present.
In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Esophageal Injury</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Gastroesophageal Reflux Disease (GERD)</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Esophageal Acid Exposure at 24h pH Monitoring</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Acid Exposure at 24h pH Monitoring in Upright Position</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Acid Exposure at 24h pH Monitoring in Supine Position</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Increased Acid Exposure</measure>
    <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
    <description>Increased Acid Exposure occurs when esophageal pH is &lt;4 for a period longer than 4% of the total test time on a 24h pH monitoring.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Patients assessed for GERD</arm_group_label>
    <description>Patients who had an open gastric bypass were assessed for GERD before and after surgery following the Montreal Consensus through a validated questionnaire in Portuguese language</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastric bypass</intervention_name>
    <description>Open Silastic® ring Roux-en Y gastric bypass was performed through an upper midline incision. A gastric pouch was created by dividing the stomach with a 10-cm stapler from the lesser curvature (7 cm vertically from the cardia) to 1 cm to the left of the Hiss angle. The estimated volume of the gastric pouch was 20 to 30 ml that was banded with a 6.5 cm long Silastic® ring. A gastrojejunal anastomosis was performed with two-layers hand sewn absorbable suture over a 1.2 cm bougie distal to the ring, keeping an alimentary limb with 100 cm in length, and a biliopancreatic limb ranging 60 and 80 cm.</description>
    <arm_group_label>Patients assessed for GERD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Morbid obesity

          -  Acceptance to undergo open gastric bypass

        Exclusion Criteria:

          -  Prior gastroesophageal surgery

          -  Achalasia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos AS Madalosso, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Gastrobese</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clínica Gastrobese</name>
      <address>
        <city>Passo Fundo</city>
        <state>RS</state>
        <zip>99010112</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2009</study_first_submitted>
  <study_first_submitted_qc>August 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2009</study_first_posted>
  <results_first_submitted>December 4, 2013</results_first_submitted>
  <results_first_submitted_qc>February 25, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 4, 2014</results_first_posted>
  <last_update_submitted>February 25, 2014</last_update_submitted>
  <last_update_submitted_qc>February 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinica Gastrobese</investigator_affiliation>
    <investigator_full_name>Carlos AS Madalosso</investigator_full_name>
    <investigator_title>Director of Department of Metabolic and Bariatric Surgery</investigator_title>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>Gastric bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>126 consecutive patients were assessed on site (Gastrobese Clinic) between March and October 2007, 94 met the criteria.
8 patients were lost to follow-up, 4 before and 4 after GBP. Out of those, 15 were lost to follow-up and 18 refused to follow through, resulting on the actual 53 patients.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients Assessed for GERD</title>
          <description>Patients assessed for GERD before and after Gastric Bypass Surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Before GBP</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>6 Months After GBP</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Patients were enrolled irrespective of GERD symptoms according to the following criteria:
age between 18 and 70 years,
BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 combined with significant comorbidities,
absence of gastroesophageal surgery, and
consent to undergo open GBP</population>
      <group_list>
        <group group_id="B1">
          <title>Patients Assessed for GERD</title>
          <description>Patients who had an open gastric bypass were assessed for GERD before and after surgery.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.26" spread="11.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Presenting Reflux Symptoms</title>
        <description>Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present.
In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Presenting Reflux Symptoms</title>
          <description>Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present.
In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>P value adjusted for multiple comparisons</p_value_desc>
            <method>Friedman´s test</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Esophageal Injury</title>
        <description>Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Esophageal Injury</title>
          <description>Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>Friedman´s test</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Gastroesophageal Reflux Disease (GERD)</title>
        <description>Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Gastroesophageal Reflux Disease (GERD)</title>
          <description>Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.001</p_value>
            <method>Friedman´s test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Esophageal Acid Exposure at 24h pH Monitoring</title>
        <description>Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Total Esophageal Acid Exposure at 24h pH Monitoring</title>
          <description>Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.</description>
          <units>percentage of time</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" lower_limit="2.3" upper_limit="8.0"/>
                    <measurement group_id="O2" value="1.2" lower_limit="0.3" upper_limit="6.3"/>
                    <measurement group_id="O3" value="0.1" lower_limit="0.0" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.020</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Esophageal Acid Exposure at 24h pH Monitoring in Upright Position</title>
        <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Esophageal Acid Exposure at 24h pH Monitoring in Upright Position</title>
          <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position</description>
          <units>percentage of time</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" lower_limit="3.6" upper_limit="8.7"/>
                    <measurement group_id="O2" value="0.8" lower_limit="0.2" upper_limit="2.7"/>
                    <measurement group_id="O3" value="0.1" lower_limit="0.0" upper_limit="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Esophageal Acid Exposure at 24h pH Monitoring in Supine Position</title>
        <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Esophageal Acid Exposure at 24h pH Monitoring in Supine Position</title>
          <description>Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position</description>
          <units>percentage of time</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="0.1" upper_limit="6.3"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Increased Acid Exposure</title>
        <description>Increased Acid Exposure occurs when esophageal pH is &lt;4 for a period longer than 4% of the total test time on a 24h pH monitoring.</description>
        <time_frame>Before GBP, 6 months after GBP and 39 months after GBP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before GBP</title>
            <description>Patients assessed for GERD before Gastric Bypass Surgery</description>
          </group>
          <group group_id="O2">
            <title>6 Months After GBP</title>
            <description>Patients assessed for GERD 6 months after Gastric Bypass Surgery</description>
          </group>
          <group group_id="O3">
            <title>39 Months After GBP</title>
            <description>Patients assessed for GERD 39 months after Gastric Bypass Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Increased Acid Exposure</title>
          <description>Increased Acid Exposure occurs when esophageal pH is &lt;4 for a period longer than 4% of the total test time on a 24h pH monitoring.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.001</p_value>
            <method>Friedman´s test</method>
            <method_desc>followed by nonparametric pairwise multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious and Other Non-Serious Adverse Events were not collected/assessed during the study</desc>
      <group_list>
        <group group_id="E1">
          <title>Patients Assessed for GERD</title>
          <description>Patients who had an open gastric bypass were assessed for GERD before and after surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery</name_or_title>
      <organization>Clinica Gastrobese</organization>
      <phone>+55(54)3045-4070</phone>
      <email>madalosso@gastrobese.com.br</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

